1. Targeting Immunity in End-Stage Renal Disease
Baragetti et al. Am J Nephrol 2017;45:   (DOI: / )
Table 1. Evidence of a relationship between inflammation markers and cardiovascular risk

2. Targeting Immunity in End-Stage Renal Disease
Baragetti et al. Am J Nephrol 2017;45:   (DOI: / )
Table 2. Experimental therapies aimed at reducing inflammation in preclinical models of CKD and ESRD

3. Targeting Immunity in End-Stage Renal Disease
Baragetti et al. Am J Nephrol 2017;45:   (DOI: / )
Fig. 1. Schematic attempt to show pathways that may be targeted or are currently being targeted in ESRD.